This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
SNAP25 / Synaptosomal-associated protein 25 · IHC design guide
Design Immunohistochemistry for SNAP25
Plan chromogenic SNAP25 IHC on paraffin sections using the high neuropil staining in cerebral cortex and cerebellum as reference patterns (HPA tissue IHC). This guide covers fixation, retrieval, antibody dilution, detection and scoring for the catalog antibody.
Evidence assembled Oct 2026 · For research use; verify linked source records and product datasheet before use
SNAP25 Immunohistochemistry Experimental Design Guide
Expected localisation, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
Must know before staining
| Expected localisation | Observed neuropil staining (HPA tissue IHC) | |
| Staining pattern | High signal in cortical neuropil and cerebellar molecular-layer neuropil (HPA tissue IHC) | |
| Antigen retrieval | Citrate pH 6 HIER, heat-mediated (datasheet A01625) | |
| Positive control | Cerebellum+1 more · see all | |
| Negative control | Adipose tissue+4 more · see all |
Important caveats
Reasons your staining may differ from the expected pattern.
| Fixation | Keep fixation consistent across paraffin sections. (standard IHC practice; not target-specific) | |
| Caveat | Hippocampal and caudate neurons show low staining (HPA tissue IHC) | |
| Regulation | Brain-enriched; intensity varies by region (HPA tissue IHC) | |
| Isoform / epitope | Two isoforms; epitope mapping is unspecified (UniProt) |
Section 1
Recommended SNAP25 IHC & IF Protocols
The catalog antibody’s IHC-P protocol is accompanied by 3 published chromogenic protocols; their antibodies distinguish total or toxin-cleaved SNAP25 (PMC8502944; PMC11125604; PMC9179158).
| Sample | Paraffin-embedded rat brain tissue; fixative not specified (datasheet A01625) |
| Fixation | Image fixative and duration unreported (datasheet A01625); verify before use. |
| Sectioning | 4–5 µm sections on charged slides (standard) |
| Deparaffinisation | Xylene, graded ethanol series to water (standard) |
| Antigen retrieval | Heat retrieval: Citrate pH 6, 20 min (datasheet A01625) |
| Peroxidase block | 3% H2O2, 10 min, room temperature (standard) |
| Blocking | 10% goat serum (datasheet A01625) |
| Primary antibody | Rabbit anti-SNAP25, 0.5-1μg/ml recommended; image 2μg/ml (datasheet A01625) |
| Primary incubation | Overnight at 4 °C (datasheet A01625) |
| Detection | Streptavidin-biotin complex (SABC), DAB chromogen (datasheet A01625) |
| Counterstain | Hematoxylin, blue, dehydrate and mount (standard) |
| Expected result | SNAP25-positive staining in molecular layer - neuropil of cerebellum (HPA tissue IHC: High). HPA tissue profile: Distinct expression CNS. No signal in the no-primary control. |
💡Decision noteStart with citrate pH 6 heat retrieval for the catalog antibody (datasheet A01625); these articles specify heat retrieval but omit the buffer (PMC8502944; PMC11125604; PMC9179158).
Section 2
What Is the Expected SNAP25 Staining Pattern?
SNAP25 is associated with the cell membrane and synaptosomes, and is also reported in the cytoplasm with perinuclear concentration; membrane association requires palmitoylation, despite the absence of a transmembrane segment (UniProt P60880). In paraffin-section IHC, expect the clearest staining in CNS neuropil, especially cerebellar molecular layer and cerebral cortex (HPA tissue IHC: High). HPA rates the tissue staining profile Enhanced, with high consistency between antibody staining and RNA expression (HPA tissue IHC).
| Strong staining across cerebellar molecular-layer neuropil or cerebral-cortex neuropil, with tissue structures still discernible. | This matches the reported High neuropil signal in both regions (HPA tissue IHC). Interpret the stained processes and neuropil in their anatomical context; the supplied tissue images establish a neuropil pattern, not a requirement for every neuronal soma to stain equally. |
| Signal appears confined to nuclei, or forms strong deposits unrelated to neuronal processes. | Nuclear-only staining conflicts with the reported membrane, cytoplasmic, perinuclear and synaptosomal locations (UniProt P60880). Check morphology and controls before scoring it as SNAP25; misplaced chromogen may reflect staining artefact rather than target localization (general IHC practice). |
| Strong signal appears in adipocytes or glandular cells in a tissue listed as negative. | HPA reports Not detected in adipose adipocytes and adrenal glandular cells (HPA tissue IHC). Review staining specificity and endogenous detection activity; unexpected signal can indicate cross-reactivity or assay background, but this observation alone cannot identify the cause (general IHC practice). |
| Chromogen is broadly diffuse, obscures tissue boundaries, or also colors the negative control. | A widespread haze cannot be confidently assigned to the reported CNS neuropil pattern (HPA tissue IHC). Evaluate nonspecific binding, detection background and washing with appropriate controls before interpreting regional staining (general IHC practice). |
| No staining appears in cerebellar molecular layer or cerebral-cortex neuropil. | Both are reported High and serve as useful positive tissue comparators (HPA tissue IHC). First check that the section contains the relevant neuropil; then inspect controls, reagent performance and the validated IHC procedure (general IHC practice). |
💡Expected SNAP25 appearanceCall a convincing positive when cerebellar molecular-layer or cerebral-cortex neuropil shows clear, strong staining (HPA tissue IHC: High); isolated nuclear deposits or comparable staining in HPA-negative cell populations warrant investigation (UniProt P60880 localization; HPA tissue IHC).
| Tissue and cell context | HPA reports High neuropil staining in cerebellar molecular layer and cerebral cortex, but Low staining in hippocampal and caudate neuronal cells (HPA tissue IHC). Compare like cell populations; a weaker neuronal-cell result in those latter regions does not by itself contradict the reported tissue profile. |
| Membrane association and compartment | SNAP25 lacks a transmembrane segment, and its membrane association requires palmitoylation (UniProt P60880). Interpret membrane-associated and synaptic-region signal alongside its reported cytoplasmic and perinuclear localization; do not require staining to trace a continuous membrane outline. |
| Antibody evidence and epitope limits | Three listed antibodies have Enhanced IHC status: HPA001830, HPA071013 and CAB000360 (HPA antibodies). The payload gives no epitope position or target-specific retrieval sensitivity, so this evidence cannot predict which retrieval condition will work best for another antibody. |
| IF/ICC appearance? | For the separate IF/ICC guide, HPA reports an approved main plasma-membrane location and additional vesicle localization (HPA subcellular ICC-IF). These cell-image observations provide a compartment reference; they do not establish an IF staining pattern for every tissue section. |
| Situation | Likely cause | Next action |
|---|---|---|
| Positive-control CNS section is blank. | The expected High neuropil population may be absent from the viewed area, or the IHC run may have failed (HPA tissue IHC; general IHC practice). | Locate cerebellar molecular layer or cortical neuropil, then review the run controls and the IHC-validated antibody's procedure and detection steps (HPA tissue IHC; general IHC practice). |
| Only nuclei stain in a purported positive region. | Nuclear-only signal does not match reported SNAP25 compartments (UniProt P60880). | Compare the deposit with cell and neuropil morphology, inspect controls, and reassess specificity before scoring a positive (general IHC practice). |
| Negative tissues show strong widespread chromogen. | This conflicts with the listed Not detected cell populations and may arise from nonspecific binding or endogenous detection activity (HPA tissue IHC; general IHC practice). | Check a no-primary control and the detection-system controls; address background according to the assay chemistry before interpreting the sample (general IHC practice). |
| A hippocampal or caudate neuronal-cell field looks faint. | HPA lists Low neuronal-cell staining in these regions (HPA tissue IHC). | Compare it with the same cell type and a High neuropil positive tissue; do not call the run failed solely because these neuronal cells are weak (HPA tissue IHC). |
| Diffuse staining makes neuropil boundaries hard to judge. | Background can mask the region-specific pattern reported by HPA (HPA tissue IHC; general IHC practice). | Inspect negative controls, review blocking and washing, and optimize detection using the validated IHC procedure before assigning regional scores (general IHC practice). |
| Two antibodies yield different distributions. | Enhanced IHC status supports the listed antibodies' validation, but does not prove every deposit from either antibody is target-specific (HPA antibodies). | Compare their staining in the same High and Not detected cell populations, then retain only patterns consistent with tissue morphology and controls (HPA tissue IHC; general IHC practice). |
Experiment evidence
IHC & IF images showing SNAP25 staining
A01625 · IHCIHC analysis of SNAP25 using anti-SNAP25 antibody (A01625). SNAP25 was detected in paraffin-embedded section of rat brain tissue. Heat media
A01625 · IHCIHC analysis of SNAP25 using anti-SNAP25 antibody (A01625). SNAP25 was detected in paraffin-embedded section of rat brain tissue. Heat media
A01625 · IFIF analysis of SNAP25 using anti- SNAP25 antibody (A01625). SNAP25 was detected in immunocytochemical section of SH-SY5Y cells. Enzyme antig
M01625 · IFImmunofluorescent analysis using the Antibody at 1:50 dilution.
HPA · Cerebral cortexHuman Protein Atlas IHC, Cerebral cortex. Source: https://www.proteinatlas.org/ENSG00000132639-SNAP25/tissue/cerebral+cortex#imid_333710
HPA · ColonHuman Protein Atlas IHC, Colon. Source: https://www.proteinatlas.org/ENSG00000132639-SNAP25/tissue/colon#imid_890398
HPA · LiverHuman Protein Atlas IHC, Liver. Source: https://www.proteinatlas.org/ENSG00000132639-SNAP25/tissue/liver#imid_333637
HPA · KidneyHuman Protein Atlas IHC, Kidney. Source: https://www.proteinatlas.org/ENSG00000132639-SNAP25/tissue/kidney#imid_333638
HPA · ICC-IF HeLaHuman Protein Atlas immunofluorescence, HeLa, antibody HPA071013; green = SNAP25, blue = nucleus, red = microtubules.
HPA · ICC-IF HeLaHuman Protein Atlas immunofluorescence, HeLa, antibody HPA071013; green = SNAP25, blue = nucleus, red = microtubules.
← swipe / scroll for more images →
Real IHC / IF data behind the staining-pattern expectations in this section.
Sample controls for SNAP25 IHC & IF
🧪Run cerebellum first and expect staining in molecular-layer neuropil (HPA: High in cerebellum molecular-layer neuropil). Use adipose tissue as the negative tissue, with adipocytes lacking detectable staining (HPA: Not detected in adipocytes); on the cerebellum slide, nuclei should remain unstained while adjacent neuropil stains (UniProt P60880 subcellular localization).
Positive control tissue: Cerebellum (Molecular layer - neuropil, HPA High)
Negative control tissue: Adipose tissue (HPA Not detected)
ICC-IF cell lines (HPA subcellular resource): HPA ICC-IF images show SNAP25 in HeLa, SH-SY5Y, U2OS, ASC52telo, RPTEC/TERT1, hTERT-RPE1 (serum starved), with annotated localisation: Plasma membrane (approved) (HPA subcellular).
Technical controls: Include a no-primary (secondary-only) slide, a concentration-matched isotype control appropriate to the primary antibody’s host and clonality, and SNAP25-knockout tissue if available; the demonstrated primary is rabbit-derived (A01625 tissue-IHC caption: rabbit anti-SNAP25). For chromogenic brain sections, quench endogenous peroxidase and check for endogenous biotin background when using the caption’s biotin-based detection system (A01625 tissue-IHC caption: biotinylated secondary, SABC and DAB).
⚠️Feasibility: The rat-brain paraffin-section example used citrate retrieval at pH 6 for 20 minutes, but does not establish whether retrieval is required (A01625 tissue-IHC caption). The fixative and any target-specific fixation window or fixation effect are unreported (A01625 tissue-IHC caption). Paraffin IHC has a demonstrated example (A01625 tissue-IHC caption); the supplied evidence does not establish that frozen sections or IF are easier, and dense neuropil staining calls for careful assessment of background (HPA: High in cerebellum molecular-layer neuropil).
HPA tissue IHC evidence for SNAP25
Comprehensive Human Protein Atlas IHC scoring per tissue (reliability: Enhanced — High consistency between antibody staining and RNA expression data.). Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
Positive expression · recommended positive controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Cerebellum | Molecular layer - neuropil | High | Protein (IHC) | HPA → |
| Cerebral cortex | Neuropil | High | Protein (IHC) | HPA → |
Undetected expression · recommended negative controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | Adipocytes | Not detected | Protein (IHC) | HPA → |
| Adrenal gland | Glandular cells | Not detected | Protein (IHC) | HPA → |
| Appendix | Endocrine cells | Not detected | Protein (IHC) | HPA → |
| Bone marrow | Hematopoietic cells | Not detected | Protein (IHC) | HPA → |
| Breast | Adipocytes | Not detected | Protein (IHC) | HPA → |
Section 3
Advanced SNAP25 IHC Tips
Troubleshoot chromogenic SNAP25 staining in paraffin sections using the catalog antibody’s tissue result and the expected neuronal neuropil pattern (datasheet A01625; HPA tissue IHC).
Which retrieval conditions should I try first for SNAP25 paraffin sections?
Start with heat-mediated citrate buffer at pH 6 for 20 minutes (datasheet A01625). The catalog antibody produced SNAP25 staining in a paraffin-embedded rat brain section after this retrieval, followed by 2 µg/mL primary antibody overnight at 4°C (datasheet A01625). If staining is weak, check heating consistency and section attachment before comparing a second retrieval condition on adjacent sections under otherwise matched processing (standard IHC practice). Assess signal in neuropil alongside background in tissue expected to lack detectable staining, since an apparent gain from stronger retrieval may also increase nonspecific chromogen (HPA tissue IHC; standard IHC practice).
Could fixation explain weak or uneven SNAP25 staining?
Target-specific fixation sensitivity is unknown from the supplied evidence; the catalog caption identifies a paraffin-embedded rat brain section but does not state its fixative (datasheet A01625). Record fixative, fixation duration, and section age for each sample, then compare matched sections while holding citrate pH 6 retrieval and antibody incubation constant (standard IHC practice; datasheet A01625). Examine whether weak staining tracks processing batches or appears within otherwise comparable neuronal regions, using an established positive tissue section in the same run (standard IHC practice; HPA tissue IHC). Avoid attributing a fixation effect to SNAP25 without a controlled comparison, because the available tissue pattern establishes expected staining locations rather than fixation tolerance (HPA tissue IHC; datasheet A01625).
Where should SNAP25 staining appear, and when is its distribution suspicious?
Expect prominent neuropil staining in cerebral cortex and the cerebellar molecular layer, where tissue IHC reports high signal (HPA tissue IHC). SNAP25 is associated with the cell membrane and synaptosome and also occurs in cytoplasm, particularly near the nucleus; its membrane association requires palmitoylation despite the absence of a transmembrane segment (UniProt P60880). Evaluate cellular outlines and neuropil separately rather than treating every brown neuronal profile as equivalent evidence of synaptic staining (UniProt P60880; HPA tissue IHC; standard IHC practice). Predominantly nuclear staining, diffuse staining across expected-negative compartments, or signal concentrated at section edges merits review of counterstain, detection controls, and tissue integrity before interpretation (UniProt P60880; HPA tissue IHC; standard IHC practice).
Can this antibody distinguish SNAP25 isoforms or phosphorylation states in tissue?
The record lists 2 SNAP25 isoforms and phosphorylation sites including residues 138, 154, and 187 (UniProt P60880). The supplied catalog tissue caption establishes staining after citrate pH 6 retrieval, but provides no epitope map or isoform-specific validation (datasheet A01625). Interpret chromogenic signal as antibody-reactive SNAP25 unless epitope mapping and appropriately controlled samples establish which isoform or modification is detected (datasheet A01625; standard IHC practice). If a biological comparison hinges on an isoform or phosphosite, obtain that validation before scoring sections, because a changed staining pattern alone cannot identify the molecular species responsible (UniProt P60880; standard IHC practice).
How should I adapt the SNAP25 question to multiplex immunofluorescence?
On the separate IF/ICC workflow, pair SNAP25 with a neuronal marker and examine whether the signals occupy the expected cellular and neuropil regions (UniProt P60880; HPA tissue IHC; standard IF practice). Select spectrally separated fluorophores after inspecting unstained tissue for autofluorescence, and include single-label controls to assess channel bleed-through (standard IF practice). Choose permeabilisation according to the antibody epitope’s accessibility: SNAP25 has no transmembrane segment, while membrane association requires palmitoylation, so membrane staining alone does not establish which side an unmapped epitope can be reached from (UniProt P60880; standard IF practice). Optimise permeabilisation against morphology and background using the IF antibody’s own validation; the paraffin tissue caption documents chromogenic IHC conditions only (datasheet A01625; standard IF practice).
How can I reduce brown background without losing genuine neuropil signal?
The catalog tissue image used 10% goat serum blocking, biotinylated goat anti-rabbit secondary antibody, an avidin-biotin detection complex, and DAB (datasheet A01625). Use a peroxidase block and a no-primary control to identify endogenous enzyme activity and detection-system background in the chromogenic workflow (standard IHC practice). If diffuse color persists, compare shorter DAB development or a primary-antibody titration against the documented 2 µg/mL condition on adjacent sections (datasheet A01625; standard IHC practice). Keep exposure and development matched across comparison slides, and protect the high neuropil signal expected in cortex and cerebellar molecular layer when choosing a cleaner condition (HPA tissue IHC; standard IHC practice).
What is a defensible way to quantify SNAP25 chromogenic staining? ⚠ ANSWER MARKED FOR VERIFICATION
Define neuronal neuropil regions before scoring, because high SNAP25 staining is reported in cerebral cortex neuropil and cerebellar molecular-layer neuropil (HPA tissue IHC). For these regions, measure DAB-positive area or optical density per mm² of viable tissue, with a fixed threshold and matched acquisition settings across slides (HPA tissue IHC; standard IHC practice). Normalise to analysed neuropil area and report section-level measurements rather than substituting a cell H-score for a predominantly neuropil signal (HPA tissue IHC; standard IHC practice). If scoring neuronal somata separately, report the percentage of positive cells or an H-score with its compartment and threshold specified, alongside control-slide performance (standard IHC practice).
How do I distinguish convincing SNAP25 staining from an artefact?
A convincing pattern includes neuropil signal in cerebral cortex or cerebellar molecular layer, both reported as high in tissue IHC (HPA tissue IHC). Interpret membrane-associated and cytoplasmic staining in light of SNAP25’s documented localisation, while treating isolated strong nuclear staining as a reason to investigate specificity (UniProt P60880; standard IHC practice). Review section edges, damaged or necrotic areas, and no-primary controls for staining that follows tissue damage or endogenous enzyme activity rather than neuronal structures (standard IHC practice). Compare with the same-run positive section and expected-negative tissue compartments, but avoid treating a negative compartment alone as proof of antibody specificity (HPA tissue IHC; standard IHC practice).
Boster reagents
Best SNAP25 / Synaptosomal-associated protein 25 IHC Antibodies
A01625 has IHC images from paraffin sections of rat and mouse brain and human glioma (A01625 IHC captions); A01625 and M01625 have IF images (catalog IF captions).
Real IHC data
Anti-SNAP25 Antibody ®
Cat # A01625
Real IF data
Anti-SNAP25 Rabbit Monoclonal Antibody
Cat # M01625
A01625 has IHC images from paraffin sections of rat and mouse brain and human glioma, plus IF data from SH-SY5Y cells (A01625 image captions). M01625 lists IF/ICC and human, mouse, and rat reactivity; its IF image caption gives no specimen (M01625 catalog applications, reactivity, and IF caption).
Which to pick: Choose A01625 for tissue IHC: its captions document paraffin sections with citrate retrieval at pH 6; the fixative is unreported (A01625 IHC captions). For IF/ICC, A01625 has SH-SY5Y cell data, while M01625 is a rabbit monoclonal option with an IF image at 1:50 but no named specimen (A01625 IF caption; M01625 catalog host, clone, applications, and IF caption). For work across human, mouse, and rat tissues, A01625 has direct IHC images from all three species (A01625 IHC captions).
Each figure is that product's own IHC / IF validation image from its datasheet.
References
- UniProt Consortium. UniProt entry P60880 (SNP25_HUMAN, Synaptosomal-associated protein 25).
- Human Protein Atlas. SNAP25 tissue IHC expression (reliability: Enhanced).
- Human Protein Atlas. SNAP25 subcellular location (ICC-IF): Mainly localized to the plasma membrane. In addition localized to vesicles..
- Human Protein Atlas. SNAP25 antibody validation summary (3 antibodies).
- Recombinant botulinum neurotoxin serotype A1 in vivo characterization. Pharmacology research & perspectives 2021 — PMC8502944.
- Intramuscular Botulinum Neurotoxin Serotypes E and A Elicit Distinct Effects on SNAP25 Protein Fragments, Muscular Histology, Spread and Neuronal Transport: An Integrated Histology-Based Study in the Rat. Toxins 2024 — PMC11125604.
- SNAP25-induced MYC upregulation promotes high-grade neuroendocrine lung carcinoma progression. Frontiers in immunology 2024 — PMC11486671.
- Evaluation of Recombinant Botulinum Neurotoxin Type A1 Efficacy in Peripheral Inflammatory Pain in Mice. Frontiers in molecular neuroscience 2022 — PMC9179158.
- PubMed PMID:8112622 — UniProt-cited evidence.
- PubMed PMID:8056350 — UniProt-cited evidence.
- PubMed PMID:8760387 — UniProt-cited evidence.
Immunohistochemistry protocol sheet for SNAP25 (Synaptosomal-associated protein 25). Expected localisation Observed neuropil staining (HPA tissue IHC). Antigen retrieval: Citrate pH 6 HIER, heat-mediated (datasheet A01625). Validated IHC antibody: A01625 at 0.5-1μg/ml recommended; image 2μg/ml (the product's own IHC validation image is shown). Controls (HPA): positive Cerebellum (Molecular layer - neuropil); negative Adipose tissue. IHC-P workflow on paraffin sections; fixative unspecified. Protocol steps: 1. Sample: Paraffin-embedded rat brain tissue; fixative not specified (datasheet A01625); 2. Fixation: Image fixative and duration unreported (datasheet A01625); verify before use.; 3. Sectioning: 4–5 µm sections on charged slides (standard); 4. Deparaffinisation: Xylene, graded ethanol series to water (standard); 5. Antigen retrieval: Heat retrieval: Citrate pH 6 , 20 min (datasheet A01625); 6. Peroxidase block: 3% H2O2, 10 min , room temperature (standard); 7. Blocking: 10% goat serum (datasheet A01625); 8. Primary antibody: Rabbit anti-SNAP25, 0.5-1μg/ml recommended; image 2μg/ml (datasheet A01625); 9. Primary incubation: Overnight at 4 °C (datasheet A01625). Watch for: Fixation: Keep fixation consistent across paraffin sections. (standard IHC practice; not target-specific); Caveat: Hippocampal and caudate neurons show low staining (HPA tissue IHC); Isoform / epitope: Two isoforms; epitope mapping is unspecified (UniProt); Regulation: Brain-enriched; intensity varies by region (HPA tissue IHC). Evidence: UniProt P60880, HPA tissue IHC · Enhanced, HPA ICC-IF · Mainly localized to the plasma membrane. In addition localized to…, Datasheet A01625, PMC8502944, PMC11125604. QR code links to https://www.bosterbio.com/bosterbio-gene-info-cards/SNAP25/immunohistochemistry-ihc-guide.